3rd Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property, data exclusivity and patent eligibility, generally; CREATES Act of 2019 (S.340)/(H.R.965); Preserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); Affordable Prescriptions for Patients Act (S.1416); Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3391); Affordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398); Protecting Consumer Access to Generic Drugs Act (H.R. 1499).

LobbyistCovered position, as disclosed
ANDREA LARUE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4398 (116th), H.R. 965 (116th), H.R. 1499 (116th), H.R. 2375 (116th), S. 64 (116th), H.R. 2374 (116th), S. 340 (116th), S. 1416 (116th), H.R. 3391 (116th), S. 1224 (116th)

Health Issues HCR

FDA - rare and orphan disease issues; Prescription drug coverage and payment policies; Medical innovation issues.

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.